NCT06419985View on ClinicalTrials.gov

Ketamine HCl Prolonged Release Oral Tablets for CRPS

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

July 31, 2027

Study Completion Date

January 31, 2028

Conditions
Complex Regional Pain Syndromes
Interventions
DRUG

80mg/day Ketamine HCl Prolonged Release

Administration of Ketamine HCl Prolonged Release - 40mg BID

DRUG

160mg/day Ketamine HCl Prolonged Release

Administration of Ketamine HCl Prolonged Release - 80mg BID

Trial Locations (1)

90033

Pain Center, Keck Medical Center of University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER